Education
About Us
Working with TipRanks
Follow Us
Fred E. Cohen Insider Profile
4 Followers
Fred E. Cohen, Director at Genomic Health, holds 155.26K shares in CareDx (Ticker: CDNA), holds 57.45K shares in Intellia Therapeutics (Ticker: NTLA), holds 4.54M shares in Kyverna Therapeutics, Inc. (Ticker: KYTX).
Profitable Transactions
0 out of 3 Profitable Transactions
Average Return
-37.80%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Fred E. Cohen holds in companies
Most Profitable Insider Trade
The most profitable trade made by Fred E. Cohen
Fred E. Cohen's Trading History
Genomic Health
Nov 14, 2019
―
Uninformative Sell
―
$0.00
Intellia Therapeutics
Jun 13, 2025
Director
Uninformative Buy
―
$1.47M
Urogen Pharma
Jul 28, 2023
Director
Uninformative Buy
661.49K
$1.32M
Progyny
May 28, 2024
Director
Uninformative Buy
―
$442.29K
Kyverna Therapeutics, Inc.
Jun 02, 2025
Director, Ten Percent Owner
Uninformative Buy
―
$33.78M
BioCryst
Sep 20, 2017
Director
Uninformative Buy
231.65K
$753.62K
CareDx
Jun 17, 2025
Director
Uninformative Buy
―
$2.32M
Five Prime Therapeutics
Jul 03, 2014
―
Uninformative Buy
―
$942.67K
Tandem Diabetes Care
―
Director
―
$0.00
Veracyte
Oct 20, 2020
Director
Uninformative Buy
76.00K
$367.30K
Sorrento Tech Inc
―
―
―
$0.00
IQVIA Holdings
―
Director
―
$0.00
List of latest transactions for each holding click on a transaction to see Fred E. Cohen's performance on stock
You May Also Like
Fred E. Cohen insider profile FAQ
What is the percentage of profitable transactions made by Fred E. Cohen?
The percentage of profitable transactions made by Fred E. Cohen is 0%.
What is the average return per transaction made by Fred E. Cohen?
The average return per transaction made by Fred E. Cohen is -37.80%.
What stocks does Fred E. Cohen hold?
Fred E. Cohen holds: GHDX, NTLA, URGN, PGNY, KYTX, BCRX, CDNA, FPRX, TNDM, VCYT, ROKA, IQV stocks.
What was Fred E. Cohen’s latest transaction?
Fred E. Cohen latest transaction was an Uninformative Buy of ―.
What was Fred E. Cohen's most profitable transaction?
Fred E. Cohen’s most profitable transaction was an Informative Buy of BCRX stock on January 9, 2015. The return on the trade was -30.50%.
What is Fred E. Cohen's role in Genomic Health?
Fred E. Cohen's role in Genomic Health is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.